Filing Details
- Accession Number:
- 0000911916-20-000135
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-22 19:51:46
- Reporting Period:
- 2020-06-22
- Accepted Time:
- 2020-06-22 19:51:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 819050 | Brickell Biotech Inc. | BBI | Biological Products, (No Disgnostic Substances) (2836) | 930948554 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1784380 | Deepak Chadha | C/O Brickell Biotech, Inc. 5777 Central Avenue, Suite 102 Boulder CO 80301 | Chief Research & Dev. Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-06-22 | 26,087 | $0.00 | 46,717 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Warrants (right to buy) | Acquisiton | 2020-06-22 | 26,087 | $0.00 | 26,087 | $1.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 26,087 | 2020-06-22 | 2025-06-22 | No | 4 | P | Direct |
Footnotes
- The reported securities were purchased by the reporting person at a combined public offering price of $1.15 per share of common stock and accompanying warrant exercisable for one share of common stock.
Billionaire Hedge Funds
